top of page

COVID-19 Research

  • Writer: Logan Rector
    Logan Rector
  • Jul 22, 2024
  • 1 min read

Updated: Dec 4, 2024

We used structure-activity relationships to identify new compounds that inhibit the SARS-CoV-2 main protease. Four rules for designing effective inhibitors have been proposed, guiding medicinal chemists in the search for potential treatments. A potential lead compound, GB111-NH2, has been identified based on these rules.

ree


Comments

bottom of page